What's Next: PROCEPT BioRobotics's Earnings Preview
Benzinga Insights 8 months ago
Earnings
PROCEPT BioRobotics (NASDAQ:PRCT) is preparing to release its quarterly earnings on Wednesday, 2026-02-25. Here's a brief overview of what investors should keep in mind before the announcement.
Analysts expect PROCEPT BioRobotics to report an earnings per share (EPS) of $-0.32.
PROCEPT BioRobotics bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
Earnings History Snapshot
The company's EPS beat by $0.04 in the last quarter, leading to a 9.74% drop in the share price on the following day.
Here's a look at PROCEPT BioRobotics's past performance and the resulting price change:
| Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| EPS Estimate | -0.42 | -0.41 | -0.49 | -0.35 |
| EPS Actual | -0.38 | -0.35 | -0.45 | -0.35 |
| Price Change % | -10.00 | -13.00 | 0.00 | 9.00 |
Market Performance of PROCEPT BioRobotics's Stock
Shares of PROCEPT BioRobotics were trading at $27.36 as of February 23. Over the last 52-week period, shares are down 59.96%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release.
Analysts' Take on PROCEPT BioRobotics
For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding PROCEPT BioRobotics.
The consensus rating for PROCEPT BioRobotics is , derived from analyst ratings. An average one-year price target of $ implies a potential .
To track all earnings releases for PROCEPT BioRobotics visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.